Business Wire

India: The Up-and-Coming Solar Market

26.3.2026 17:27:00 EET | Business Wire | Press release

Share

Solar energy expansion is booming worldwide. India, in particular, is seeing rapid growth thanks to state funding programs, tax incentives, subsidies and green loans from banks. In 2025, 37.5 gigawatts were added – a 50 percent increase from the previous year. The 2026 budget provides for a deployment of 45 to 50 gigawatts, allowing the most densely populated country to become the second largest solar market in the world. Intersolar Europe will shine a spotlight on the south Asian country from June 23–25 in Munich. India is an up-and-coming market for the international PV industry. There will be numerous events where visitors can learn about the market, new business opportunities and the structure of new supply chains. The exhibition will take place as part of The smarter E Europe, Europe’s largest alliance of exhibitions for the energy industry. More than 100,000 visitors and 2,800 exhibitors from all over the world are expected to attend.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326991766/en/

A large number of interested visitors attended Intersolar India – a key industry event in India since 2009. (©Solar Promotion GmbH)

Photovoltaics (PV) serves as the technological backbone of supply security in the expansion of renewable energies. 500 gigawatts of renewable energy are expected to be installed by 2030, including 280 gigawatts of solar energy. PV is becoming more attractive due to unprecedented price erosion: According to data from the International Renewable Energy Agency (IRENA), solar power costs in India have fallen by 80 percent since 2010, making it the most cost-effective option for new power installations.

But there are also challenges. The need for highly specialized skilled workers, the expansion of modern energy infrastructure and the scaling of storage capacity are key factors for the next transformative phase. These developments also open up enormous opportunities for collaborations and new markets. “India is both a major sales market and an attractive partner for expanding production capacity in the solar and storage industries. This also makes it a potential source for finished components and intermediate products,” says David Wedepohl, Managing Director International Affairs at the German Solar Association.

At the end of January 2026, the European Commission signed a free trade agreement with India. “Along the entire PV value chain – from module production and cells to wafers, ingots and polysilicon – India is growing to become one of the most dynamic producers in the world. The EU-India Free Trade Agreement also gives new opportunities for discussion and trade between both regions,” explains Dr. Puzant Baliozian, Sector Group Leader Photovoltaics Equipment at VDMA (German Engineering Federation). In the future, solar energy is set to expand onto reservoirs, bodies of water and agricultural land using agricultural PV and floating solar systems.

Side events at the exhibition

With support from Intersolar Europe and other partners, the German Solar Association is planning several side events at the exhibition on the topic of the India’s PV market. Together with the VDMA, they are dedicated to building joint supply chains. The VDMA, the German Solar Association and the Indian NSEFI are hosting a CEO roundtable, bringing together high-ranking industry representatives. The Indo-German Energy Forum are hosting a business dialogue to mark the free trade agreement concluded between India and the EU. On June 24, this series of events will be concluded by the India Meets EU: Solar Night – Networking Reception.

Intersolar Europe
Munich, June 23–25, 2026

For more information, please visit:
www.intersolar.de
www.TheSmarterE.de

View source version on businesswire.com: https://www.businesswire.com/news/home/20260326991766/en/

Contacts

Press contact:
RYSM | Schlesische Straße 26/c4 |10997 Berlin
Roberto Freiberger | Tel.: +49 163 8430 943
roberto.freiberger@rysm.com

Solar Promotion GmbH | P.O. Box 100 170 | 75101 Pforzheim
Peggy Härter-Zilay | Tel.: +49 7231 58598-240
haerter-zilay@solarpromotion.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting Enters Collaboration Agreement with Solutia26.3.2026 17:59:00 EET | Press release

Andersen Consulting expands its presence in Spain through a Collaboration Agreement with Solutia, a firm specializing in occupational and workplace health solutions, as well as recruitment across the life sciences and healthcare sectors. Founded in 2014, Solutia provides comprehensive services and consulting focused on healthy work environments, absenteeism, healthcare outsourcing, and training for organizations across all sectors. The firm also delivers recruitment and executive search solutions specialized in life sciences, technical professionals, and middle and executive management, with deep expertise in the pharmaceutical, biotechnology, medical technology, and healthcare industries. Solutia helps organizations enhance workforce efficiency and attract specialized talent through tailored solutions based on data. “We are committed to advancing how organizations attract, develop, and manage talent in an increasingly complex environment,” said Cesar Castel, managing director of Solut

CSG Named a Leader in the Gartner® Magic Quadrant™ for Customer Journey Analytics & Orchestration26.3.2026 17:30:00 EET | Press release

Rising customer expectations for connected, relevant, and effortless interactions are making journey analytics and orchestration critical to delivering consistent, personalized experiences that earn loyalty. As CSG® (NASDAQ: CSGS) helps businesses to meet and exceed those expectations, the company today announced that CSG has been named a Leader in the 2026 Gartner® Magic Quadrant™ for Customer Journey Analytics & Orchestration. The evaluation assessed the company’s overall Completeness of Vision and Ability to Execute. “It’s not enough to understand the customer – businesses must act on that knowledge in real time and prove the value of every customer interaction,” said Katie Costanzo, President, Customer Experience, CSG. “That requires a unified system that turns real-time data into clear decisions, measurable outcomes, and experiences customers can trust. I am incredibly proud that CSG has been named a Leader in the inaugural Gartner Magic Quadrant for Journey Analytics & Orchestrat

Vena Completes Acterys Acquisition to Accelerate Orchestrated Planning for the Microsoft Ecosystem26.3.2026 15:00:00 EET | Press release

Vena, the AI-powered Orchestrated Performance Management platform purpose-built to fully amplify the Microsoft technology ecosystem, today announced it has completed its acquisition of Acterys, the leading Microsoft Power BI–based operational planning and app development platform. The move strengthens Vena’s Orchestrated Planning solution and begins phased integration of the two platforms. Modern enterprises are struggling to keep up with the volatility and dynamism of the markets they serve. Market drivers and signals shift rapidly, and the ability to assess, plan and execute with confidence and speed is more important than ever. These forces, combined with overwhelming data density and disparity, have created a new constraint: decision latency—the time between signal and action. As that gap widens, confidence erodes and competitive advantage is lost. Orchestrated Planning removes decision latency by harmonizing data, people, processes and agentic capabilities to help organizations mo

Nearly Half of Global C-Suites Plan U.S. Expansion Within 12 Months, as Supply Chain and Capital Access Drive Growth26.3.2026 15:00:00 EET | Press release

Nearly half (45%) of global C-suite leaders plan to establish a legal entity in the United States within the next 12 months, highlighting continued demand for access to the U.S. market. This finding from the latest research by CSC—the leading provider of global business administration and compliance solutions—demonstrates the U.S. continues to attract investment from around the world, even as companies face an increasingly complex regulatory landscape. CSC surveyed 300 C-level executives at large organizations headquartered in Europe, the U.K., Asia Pacific, and South America to examine global sentiment toward U.S. market entry, including expansion plans, strategic drivers, and regulatory challenges.1 CSC’s report Navigating U.S. Market Entry: Insights, Risks, and Opportunities for Global Businesses details the results. The research highlights strong forward momentum toward U.S. expansion. In addition to the 45% planning to establish an entity within the next 12 months, a further 27% s

Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging26.3.2026 14:30:00 EET | Press release

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced preliminary results from a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial in patients with plaque psoriasis, atopic dermatitis, and skin aging (photo-aged skin). The recently completed Phase 1 clinical trial, conducted in the European Union, was designed to assess the safety, tolerability, clinical effects, plasma bioavailability, and pharmacodynamics of topical RLS-1496—the first-ever GPX4 (selective glutathione peroxidase 4) modulator to be studied in human trials, and the first specifically targeting cellular rejuvenation, an area of great interest to the scientific community as a new therapeutic pathway. The study met its primary endpoint, with RLS-1496 also demonstrating early signs of efficacy. Preliminary Trial Results RLS-1496 was well-tolerated,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye